Bajaj HealthCare Limited
NSE: BAJAJHCARE BSE: BAJAJHCARE
NSE
474.50
-6.50 (-1.35%)
Prev Close
481
Open Price
485.95
Volume
114,407
Today Low / High
472.75 / 485.95
52 WK Low / High
358.9 / 745
Range
451 - 498
BSE
475.55
-5.15 (-1.07%)
Prev Close
480.7
Open Price
484.4
Volume
7,547
Today Low / High
473 / 484.4
52 WK Low / High
359.1 / 744.9
Range
452 - 499
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 474.5 (target range: 451 - 498), reflecting a change of -6.5 (-1.35135%). On the BSE, it is listed at 475.55 (target range: 452 - 499), showing a change of -5.15 (-1.07135%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
29 Oct
453.25
1.28%
28 Oct
454.80
-0.71%
27 Oct
459.85
-1.10%
24 Oct
449.60
1.57%
23 Oct
456.75
-1.57%
21 Oct
462.95
-1.34%
20 Oct
471.20
-2.43%
17 Oct
479.70
-2.12%
16 Oct
459.00
4.43%
15 Oct
461.65
-1.09%
14 Oct
459.90
0.60%
13 Oct
468.00
-2.18%
10 Oct
472.60
-0.80%
09 Oct
470.00
0.04%
08 Oct
483.60
-2.25%
07 Oct
487.55
-1.47%
06 Oct
490.05
-0.81%
03 Oct
481.90
0.45%
Bajaj HealthCare Limited Graph
Bajaj HealthCare Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Bajaj HealthCare Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 474.50, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 475.55 | 480.31 | 432.27 - 528.34 |
| 485.06 | 388.05 - 582.07 | ||
| 489.82 | 342.87 - 636.76 | ||
| Bearish Scenario | 475.55 | 470.79 | 423.72 - 517.87 |
| 466.04 | 372.83 - 559.25 | ||
| 461.28 | 322.90 - 599.67 |
Overview of Bajaj HealthCare Limited
ISIN
INE411U01027
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
236,675
Market Cap
14,498,291,831
Last Dividend
1
Official Website
IPO Date
2021-11-25
DCF Diff
949.54
DCF
-470
Financial Ratios Every Investor Needs
Stock Dividend of BAJAJHCARE
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-09-19 | September 19, 25 | 1 | 1 | 2025-09-19 | 2025-10-26 | |
| 2024-09-23 | September 23, 24 | 1 | 1 | 2024-09-23 | 2024-10-30 | |
| 2023-09-22 | September 22, 23 | 1 | 1 | 2023-09-23 | 2023-10-30 | |
| 2022-09-22 | September 22, 22 | 1.5 | 1.5 | 2022-09-23 | 2022-10-30 | |
| 2021-09-28 | September 28, 21 | 0.5 | 0.5 | 2021-09-29 | 2021-10-30 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 542.60 Cr | 371.42 Cr | 171.18 Cr | 0.3155 | 0.00 Cr | 57.06 Cr | 54.51 Cr | 39.50 Cr | 13.29 | 101.83 Cr | 0.0728 |
| 2024-03-31 | 473.42 Cr | 259.13 Cr | 214.29 Cr | 0.4526 | 1.63 Cr | 5.74 Cr | 48.71 Cr | -83.79 Cr | -30.36 | 40.62 Cr | -0.1770 |
| 2023-03-31 | 645.80 Cr | 490.66 Cr | 133.15 Cr | 0.2062 | 3.80 Cr | 47.84 Cr | 96.16 Cr | 43.02 Cr | 15.59 | 121.94 Cr | 0.0666 |
| 2022-03-31 | 679.22 Cr | 495.39 Cr | 183.84 Cr | 0.2707 | 2.61 Cr | 6.96 Cr | 105.95 Cr | 71.39 Cr | 25.87 | 119.95 Cr | 0.1051 |
| 2021-03-31 | 655.78 Cr | 462.93 Cr | 192.86 Cr | 0.2941 | 4.53 Cr | 5.57 Cr | 124.81 Cr | 83.11 Cr | 30.11 | 143.28 Cr | 0.1267 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.60 Cr | 833.05 Cr | 366.88 Cr | 466.1642 Cr | 223.25 Cr | 218.80 Cr | 161.89 Cr | 240.49 Cr | 0.00 Cr | 0.00 Cr | 2.86 Cr | 272.2662 Cr |
| 2024-03-31 | 2.17 Cr | 765.13 Cr | 486.77 Cr | 278.3609 Cr | 332.82 Cr | 330.65 Cr | 144.04 Cr | 257.56 Cr | 0.31 Cr | 0.00 Cr | 1.95 Cr | 441.4792 Cr |
| 2023-03-31 | 17.72 Cr | 901.46 Cr | 533.77 Cr | 367.6894 Cr | 415.24 Cr | 397.52 Cr | 208.79 Cr | 387.42 Cr | 28.29 Cr | 2.79 Cr | 9.84 Cr | 436.0596 Cr |
| 2022-03-31 | 1.98 Cr | 721.10 Cr | 392.62 Cr | 328.4855 Cr | 256.74 Cr | 254.76 Cr | 159.26 Cr | 321.72 Cr | 25.56 Cr | 68.98 Cr | 0.00 Cr | 322.0730 Cr |
| 2021-03-31 | 14.24 Cr | 525.63 Cr | 267.22 Cr | 258.4105 Cr | 180.89 Cr | 166.64 Cr | 97.11 Cr | 265.18 Cr | 10.95 Cr | 0.00 Cr | -0.66 Cr | 182.5733 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -5.7780 Cr | -15.3210 Cr | 21.5281 Cr | -17.3165 Cr | 2.2761 Cr | 4.4508 Cr | -11.5385 Cr | 42.9288 Cr | -125.2805 Cr | -2.7598 Cr | -17.8495 Cr |
| 2024-03-31 | 92.2944 Cr | -11.2446 Cr | -96.5955 Cr | 62.0081 Cr | -15.5457 Cr | 2.1747 Cr | -30.2863 Cr | -14.3266 Cr | -51.7296 Cr | -2.7598 Cr | 20.4204 Cr |
| 2023-03-31 | -22.3237 Cr | -93.4267 Cr | 131.4958 Cr | -146.1657 Cr | 15.7454 Cr | 17.7204 Cr | -123.8420 Cr | 58.2163 Cr | 158.5079 Cr | -4.1398 Cr | -49.5249 Cr |
| 2022-03-31 | 0.6860 Cr | -74.7984 Cr | 61.8463 Cr | -78.6189 Cr | -12.2662 Cr | 1.9749 Cr | -79.3049 Cr | 89.6846 Cr | 75.8501 Cr | -1.3800 Cr | -62.1515 Cr |
| 2021-03-31 | 43.5583 Cr | -108.9330 Cr | 75.4573 Cr | -70.2304 Cr | 10.0826 Cr | 14.2411 Cr | -113.7887 Cr | 118.8197 Cr | 86.1681 Cr | -2.4149 Cr | -57.8352 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 148.84 Cr | 80.59 Cr | 68.25 Cr | 0.4585 | 18.87 Cr | 11.83 Cr | 3.74 | 25.39 Cr | 0.0795 |
| 2025-03-31 | 154.47 Cr | 117.21 Cr | 37.27 Cr | 0.2413 | 4.23 Cr | 11.18 Cr | 3.48 | 25.33 Cr | 0.0724 |
| 2024-12-31 | 122.79 Cr | 60.91 Cr | 61.88 Cr | 0.5039 | 14.79 Cr | 11.72 Cr | 3.65 | 24.01 Cr | 0.0955 |
| 2024-09-30 | 133.09 Cr | 65.98 Cr | 67.11 Cr | 0.5042 | 17.72 Cr | 9.46 Cr | 3.36 | 27.13 Cr | 0.0711 |
| 2024-06-30 | 132.25 Cr | 65.58 Cr | 66.66 Cr | 0.5041 | 17.77 Cr | 7.13 Cr | 2.58 | 24.50 Cr | 0.0539 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 4.45 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -466.16 Cr |
| 2025-03-31 | 4.45 Cr | 1.85 Cr | 4.45 Cr | 251.67 Cr | 161.89 Cr | 485.40 Cr | 240.49 Cr | 833.05 Cr | 366.88 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 22.84 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -445.83 Cr |
| 2024-09-30 | 21.47 Cr | 36.53 Cr | 58.00 Cr | 216.86 Cr | 142.43 Cr | 531.07 Cr | 248.29 Cr | 803.95 Cr | 358.12 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 2.93 Cr | 0.00 Cr | 0.00 Cr | 2.93 Cr | 0.00 Cr | 0.00 Cr | -278.36 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 11.83 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 11.18 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 11.72 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 9.46 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 7.13 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,690.70 | ₹4,056,549,508,373.00 | ₹1,560,907.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,738.00 | ₹1,788,732,898,056.00 | ₹507,645.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,560.10 | ₹1,204,898,044,500.00 | ₹354,021.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,197.60 | ₹996,839,216,220.00 | ₹4,250,056.00 |
| Mankind Pharma Limited | MANKIND | ₹2,384.00 | ₹984,016,240,160.00 | ₹593,366.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹974.45 | ₹980,520,395,716.00 | ₹458,971.00 |
| Lupin Limited | LUPIN | ₹1,963.50 | ₹896,844,333,000.00 | ₹1,017,447.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,138.90 | ₹661,474,968,435.00 | ₹3,556,831.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,506.50 | ₹658,384,672,500.00 | ₹178,327.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,891.20 | ₹533,698,169,981.00 | ₹398,054.00 |
| Laurus Labs Limited | LAURUSLABS | ₹953.65 | ₹514,804,014,931.00 | ₹1,545,364.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,271.20 | ₹322,508,801,922.00 | ₹106,442.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,465.30 | ₹308,003,793,847.00 | ₹102,941.00 |
| Cohance Lifesciences Limited | COHANCE | ₹753.40 | ₹288,226,083,276.00 | ₹1,868,840.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,682.30 | ₹263,441,852,870.00 | ₹161,890.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| Emcure Pharmaceuticals Ltd. | EMCURE | ₹1,318.90 | ₹250,017,076,708.00 | ₹201,166.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹9,555.00 | ₹238,875,000,000.00 | ₹20,033.00 |
| Eris Lifesciences Limited | ERIS | ₹1,591.70 | ₹216,811,113,902.00 | ₹40,393.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹16,473.00 | ₹211,346,761,497.00 | ₹44,604.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,281.50 | ₹208,224,272,482.00 | ₹289,135.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹897.40 | ₹176,395,747,478.00 | ₹69,233.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,101.00 | ₹174,564,413,184.00 | ₹543,954.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹2,032.80 | ₹154,516,575,629.00 | ₹43,860.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹819.90 | ₹146,852,182,413.00 | ₹412,467.00 |
| Granules India Limited | GRANULES | ₹565.60 | ₹137,253,425,770.00 | ₹384,397.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Alivus Life Sciences Ltd. | ALIVUS | ₹904.45 | ₹110,959,145,199.00 | ₹27,710.00 |
| Procter & Gamble Health Limited | PGHL | ₹6,152.00 | ₹102,119,398,064.00 | ₹17,413.00 |
| Strides Pharma Science Limited | STAR | ₹934.70 | ₹86,153,835,776.00 | ₹9,219,602.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹851.95 | ₹77,214,757,940.00 | ₹105,286.00 |
| FDC Limited | FDC | ₹460.65 | ₹74,998,465,195.00 | ₹252,540.00 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | ₹460.75 | ₹70,541,773,224.00 | ₹53,334.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹352.85 | ₹69,011,043,776.00 | ₹149,611.00 |
| Sequent Scientific Limited | SEQUENT | ₹214.61 | ₹53,633,796,524.00 | ₹1,034,635.00 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | ₹465.10 | ₹50,679,744,752.00 | ₹51,856.00 |
| Innova Captab Limited | INNOVACAP | ₹831.10 | ₹47,559,638,492.00 | ₹13,222.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹491.10 | ₹44,822,697,000.00 | ₹54,690.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹135.19 | ₹43,872,073,482.00 | ₹196,488.00 |
| Suven Life Sciences Limited | SUVEN | ₹197.55 | ₹43,073,939,692.00 | ₹121,404.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,403.90 | ₹39,758,138,159.00 | ₹6,281.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹726.30 | ₹36,837,285,962.00 | ₹86,074.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹470.95 | ₹33,157,587,963.00 | ₹3,282.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹325.40 | ₹32,631,927,452.00 | ₹54,623.00 |
Key Executives
Senior Vice President of Operations and Unit II Head- Salvi
Mr. Nandkumar R. Soni
Gender: male
Year Born:
Whole Time Director
Mr. Pakshal Anil Jain
Gender: male
Year Born: 1998
Chief Technical Officer
Mr. Amit Rajan M.Tech
Gender: male
Year Born:
Company Secretary & Compliance Officer
Ms. Monica Tanwar
Gender: female
Year Born:
Executive Vice President Sales & Marketing
Mr. A.G. Prasad
Gender: male
Year Born:
Whole-Time Director
Mr. Dhananjay Sabaji Hatle
Gender: male
Year Born: 1972
Whole Time Director
Ms. Namrata Sajankumar Bajaj
Gender: female
Year Born: 1986
Founder, Chairman & MD
Mr. Sajankumar Rameshwarlal Bajaj
Gender: male
Year Born: 1960
Vice Chairman & Joint MD
Mr. Anil Champalal Jain
Gender: male
Year Born: 1975
FAQs about Bajaj HealthCare Limited
Who is the CEO of the company?
The CEO is Sajankumar Rameshwarlal Bajaj.
What is the current market price of the stock?
The current price is ₹459.05.
What is the 52-week price range?
The range is ₹354.5-745.
What is the market capitalization of the company?
The market capitalization is ₹1,449.83 crores.
What is the dividend yield?
The dividend yield is 0.22%.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 32.86.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Bajaj HealthCare Limited (ISIN: INE411U01027) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹1,449.83 crores and an average daily volume of 236,675 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹1.